Scott M Coiante - Net Worth and Insider Trading
Scott M Coiante Net Worth
The estimated net worth of Scott M Coiante is at least $13,126 dollars as of 2024-05-01. Scott M Coiante is the SVP, CFO of Aprea Therapeutics Inc and owns about 2,500 shares of Aprea Therapeutics Inc (APRE) stock worth over $13,125. Scott M Coiante is also the VP and CFO of Agile Therapeutics Inc and owns about 2 shares of Agile Therapeutics Inc (AGRX) stock worth over $1. Details can be seen in Scott M Coiante's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott M Coiante has not made any transactions after 2019-10-07 and currently still holds the listed stock(s).
Transaction Summary of Scott M Coiante
Scott M Coiante Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott M Coiante owns 2 companies in total, including Aprea Therapeutics Inc (APRE) , and Agile Therapeutics Inc (AGRX) .
Click here to see the complete history of Scott M Coiante’s form 4 insider trades.
Insider Ownership Summary of Scott M Coiante
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-03-24 | SVP & Chief Financial Officer |
| AGRX | Agile Therapeutics Inc | 2023-08-16 | Chief Financial Officer |
Scott M Coiante Latest Holdings Summary
Scott M Coiante currently owns a total of 2 stocks. Among these stocks, Scott M Coiante owns 2,500 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $13,125 and a weighting of 99.99%. Scott M Coiante also owns 2 shares of Agile Therapeutics Inc (AGRX) as of May 22, 2014, with a value of $1 and a weighting of 0.01%.
Latest Holdings of Scott M Coiante
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 2,500 | 5.25 | 13,125 |
| AGRX | Agile Therapeutics Inc | 2014-05-22 | 2 | 0.44 | 1 |
Holding Weightings of Scott M Coiante
Scott M Coiante Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott M Coiante has made a total of 1 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 2,500 shares on October 7, 2019, which cost Scott M Coiante around $37,500.
According to the SEC Form 4 filings, Scott M Coiante has made a total of 0 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years. The most-recent trade in Agile Therapeutics Inc is the sale of 0 shares on May 22, 2014, which brought Scott M Coiante around $0.
Insider Trading History of Scott M Coiante
- 1
Scott M Coiante Trading Performance
GuruFocus tracks the stock performance after each of Scott M Coiante's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott M Coiante is 115.11%. GuruFocus also compares Scott M Coiante's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott M Coiante within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott M Coiante's insider trading performs compared to the benchmark.
Performance of Scott M Coiante
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.41 | | | | | |
| Relative Return to S&P 500(%) | 14.43 | | | | | |
Scott M Coiante Ownership Network
Scott M Coiante Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Scott M Coiante is the SVP & Chief Financial Officer of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Scott M Coiante made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Scott M Coiante Mailing Address
Above is the net worth, insider trading, and ownership report for Scott M Coiante. You might contact Scott M Coiante via mailing address: 101 Poor Farm Road 3rd Floor, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
